JAK2 and acute myeloid leukemia: The restoration of SHP-1, SOCS-1, and SOCS-3 expression by epigenetic modulating agents such as 5-azacytidine (5-Aza) was associated with significant inhibition of JAK2/STAT3 and STAT5 signaling in AML leukemia cells [8,12].